# Process Intensification for Recombinant Marburg Virus Glycoprotein Production Using Drosophila S2 Cells

**Authors:** Sven Göbel, Ludwig Mayerlen, Isabelle Yazel Eiser, Lisa Fichtmueller, David Clements, Udo Reichl, Yvonne Genzel, AxelT. Lehrer

PMC · DOI: 10.1002/elsc.70022 · 2025-05-19

## TL;DR

Researchers improved the production of a key protein from Marburg virus using insect cells, achieving higher yields and better control in bioreactors.

## Contribution

A novel process intensification approach using bioreactors increased MARV-GP yields and space-time productivity significantly.

## Key findings

- Perfusion mode in bioreactors achieved 210.0 × 10⁶ cells/mL and 57.4 mg/L MARV-GP.
- Switching to CellBoost5 feed increased MARV-GP yields by over two-fold.
- Glycan profiles were influenced by pH control methods, with phosphoric acid favoring higher mannose forms.

## Abstract

Marburg marburgvirus (MARV) is a highly virulent human pathogen with limited therapeutic options. Recombinant MARV glycoprotein (GP) produced in Drosophila Schneider 2 (S2) cells has been extensively investigated as potential vaccine antigen with promising efficacy demonstrated in nonhuman primate models. However, the existing production process for MARV‐GP involving static batch cell cultures with limited scalability and process control show lower than desirable yields. Here, we assessed various process intensification strategies in single‐use orbital shaken bioreactors (OSBs) or rocking bioreactors (WAVE) and report maximum viable cell concentrations (VCCs) of 31.6 × 106 cells/mL in batch, 69.5 × 106 cells/mL in fed‐batch (FB), and up to 210.0 × 106 cells/mL in perfusion mode. By changing from a glucose‐only feed to a CellBoost5 feed, MARV‐GP yields were increased by over two‐fold. Implementation of perfusion cultures achieved a peak MARV‐GP concentration of 57.4 mg/L and a 540% higher space‐time yield compared to the FB process in the 50 L WAVE system. However, maximum cell‐specific productivities were achieved at a VCC of 85 × 106 cells/mL and decreased with increasing cell concentrations. Glycoanalysis revealed a uniform paucimannosidic N‐glycan profile, predominantly α‐1,6‐core‐fucosylated Man3F (F(6)M3) structures, across all production modes. Notably, transitioning pH control from CO2 to phosphoric acid shifted glycan profiles toward higher mannose forms, highlighting the influence of culture conditions on glycosylation.

## Linked entities

- **Chemicals:** glucose (PubChem CID 5793), phosphoric acid (PubChem CID 1004)

## Full-text entities

- **Genes:** gp (gap) [NCBI Gene 251209]
- **Chemicals:** phosphoric acid (MESH:C030242), mannose (MESH:D008358), glucose (MESH:D005947), glycan (MESH:D011134), CO2 (MESH:D002245), F(6)M3 (-)
- **Species:** Drosophila melanogaster (fruit fly, species) [taxon 7227], Marburg marburgvirus [taxon 11269], Homo sapiens (human, species) [taxon 9606], Marburg Virus [taxon 186537]
- **Cell lines:** S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12087431/full.md

---
Source: https://tomesphere.com/paper/PMC12087431